| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Environmental > Climate Change in Africa |
|
Write You - Climate Change in Africa
Climatic changes on the African continent are threatening the valuable agricultural and tourism industries. These 2 areas mak According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e up a large part of Kenya’s income. A report suggests that tourism in Africa, which makes up for three per cent of the world ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s tourism, may change with climate change. The report says increased warming will induce many changes in the global climate s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. stem during the 21st century. The threat of flood risks and water pollution-related diseases in low lying regions and coral r here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ef bleaching due to climate change could impact negatively on tourism. Mozambique is growing as a tourist destination, howeve d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro in 2000 it was in the world news due to massive floods which took the lives of hundreds of people, these floods have occurred ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc again in early 2007, deterring tourist from the beautiful country. Africa is home to the best Safari parks in the world, incl easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ding the Masai Mara Game Reserve in Kenya and the Kruger National Park in South Africa, but due to global warming and climate nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hange it is expected that about 10% of the species current populations are projected to decline in coming years By 2080 it is and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ estimated that areas of arid and semi arid land in Africa are likely to increase by 5 - 8 %. Crop revenue in Africa could fa ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi l by up to 90 per cent by 2100, and wheat production - one of Africa’s greatest sources of income - in Africa might disappear ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ltogether by the 2080. If sea level was to rise by only 1 meter, the coastal areas of Kenya would loss massive areas which th dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ee main crops grow in the country, namely mangoes, cashew nuts, and coconuts, loss of these crops could cost the country almos cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin US$500 million. If sea levels do rise it is feared that costal agriculture could be at risk of inundation and soil salinatio tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Climate change will also affect human health in Africa. Malaria distribution has already increased in the past decade and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s expected to continue to move into these previously cooler areas, it is estimated that by the 2080s an additional 80 million ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eople will likely be at risk of malaria. Areas of Kenya, Ethiopia, Rwanda and Burundi which have not previously had malaria c y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products uld also experience changes which will allow malaria carrying mosquitoes to thrive there by the 2050s. Humans’ ability to rec . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ver from disease and illness could also be affected by climate change in Africa. Many countries are already suffering from ma elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip sive HIV / Aids pandemics, and with changes in moisture and temperature in the continent diseases could become harder to fight tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Heart Of Internet Entrepreneurship The Proper Way Of Filing An Advance Cash Form To Get Immediate Results Writing Book Proposals That Publishers Read
|